Marketing Small Molecule Virus White Paper 
Codon
APRIL 30, 2023
Read more at Nature Biotechnology ( Similar paper at Nature Biomedical Engineering.) If approved, these wouldn’t be the first gene therapies on the market, but they would be the first gene therapies for a disease that affects something like 100,000 Americans. Note: I’m employed by the company and a co-author on the paper.)
Codon
APRIL 30, 2023
Read more at Nature Biotechnology ( Similar paper at Nature Biomedical Engineering.) If approved, these wouldn’t be the first gene therapies on the market, but they would be the first gene therapies for a disease that affects something like 100,000 Americans. Note: I’m employed by the company and a co-author on the paper.)
Expert insights. Personalized for you.
52 
Let's personalize your content